Skip to main content
. 2014 Jan 23;7(4):977–981. doi: 10.3892/etm.2014.1496

Table II.

Adverse events during the bortezomib-based retreatment.

Adverse event Total patients Severity (grade)

I II III IV
Diarrhea 2 1 1 0
Thrombocytopenia 10 4 4 2 0
Neutropenia 8 2 4 2 0
Weakness 2 2 0 0 0
Pulmonary infection 1 0 0 1 0
Peripheral neuropathy 2 1 1 0 0
Herpes zoster 2 1 1 0 0

All data presented as number of patients. AEs, adverse events.